Bristol-Myers Squibb
IRS: 220790350BMY
Bristol-Myers Squibb Co discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders.
Founded
1989 (32 years)
CEO
Giovanni Caforio
Revenue
39 billion (2020)